Condition

Metastatic Pancreatic Carcinoma clinical trials and research

• 7Clinical trials
• 3Countries

Newest Metastatic Pancreatic Carcinoma clinical trials

All recruiting trials (7)

• BMS-986504 plus pemetrexed for MTAP-deleted metastatic solid tumors

  This study tests whether the combination of BMS-986504 and pemetrexed is safe and potentially effective for people with MTAP-deleted metastatic solid tumors.

  Recruiting Phase 1/2 Northwestern University · Chicago, Illinois · NCT07594626

• Using pemigatinib to treat advanced pancreatic cancer with FGFR genetic changes

  This study is testing if a new drug called pemigatinib can help adults with advanced pancreatic cancer that has specific genetic changes feel better and possibly live longer.

  Recruiting at 109 sites Phase 2 Ohio State University Comprehensive Cancer Center · Birmingham, Alabama and 108 other locations · NCT06906562

• HRS-4642 with nimotuzumab plus gemcitabine and nab-paclitaxel as first-line treatment for advanced pancreatic cancer with KRAS G12D

  This trial will try HRS-4642 together with nimotuzumab and standard gemcitabine/nab‑paclitaxel chemotherapy as first‑line treatment for people with metastatic pancreatic cancer whose tumors carry the KRAS G12D mutation.

  Recruiting Phase 2 Zhejiang University · Hangzhou, Zhejiang and 1 other locations · NCT06770452

• Evaluating OATD-02 for advanced solid tumors

  This study is testing a new oral medication called OATD-02 to see if it can help people with advanced solid tumors, like colorectal and ovarian cancer, by making their tumors respond better to treatment.

  Recruiting at 3 sites Phase 1 Molecure S.A. · Bydgoszcz, Kuyavian-Pomeranian Voivodeship and 2 other locations · NCT05759923

• CPI-613 combined with hydroxychloroquine and chemotherapy for advanced solid tumors

  This study is testing a new combination of treatments, including CPI-613 and hydroxychloroquine, to see if it can help people with advanced solid tumors that haven't improved with other chemotherapy.

  Recruiting Phase 2 Northwestern University · Chicago, Illinois · NCT05733000

• Testing a new drug combination for advanced cancer and lymphoma

  This study is testing a new combination of two drugs to see if it can help people with advanced cancer and lymphoma feel better and live longer.

  Recruiting at 3 sites Phase 1/2 National Cancer Institute (NCI) · New Haven, Connecticut and 2 other locations · NCT05053971

• Real-time imaging of tumor blood vessels during surgery

  We will test whether a real-time microscope technique during surgery can show how well blood vessels in adults' solid tumors work and whether that helps predict if systemic cancer medicines can reach the tumor.

  Recruiting Mayo Clinic · Jacksonville, Florida · NCT03823144

Related topics

Quick answers

How many Metastatic Pancreatic Carcinoma clinical trials are recruiting right now?

7, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.

Where are these trials running?

In 3 countries. The most sites are in United States (5 trials), Poland (1 trial), China (1 trial). Each study page lists its sites and which ones are recruiting.

What phases are they in?

Phase 2: 3, Phase 1/2: 2, Phase 1: 1. Trials with no phase listed are usually device, behavioural or observational studies.

How do I join one?

Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.

Find the studies that fit you

A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.

Describe your situation →